Epigenomics AG NA buy matumba
Start price
30.01.11
/
50%
€8.49
Target price
01.08.11
€11.00
Performance (%)
-27.52%
End price
01.08.11
€6.15
Summary
This prediction ended on 01.08.11 with a price of €6.15. The price of Epigenomics AG NA has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -27.52%. matumba has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Epigenomics AG NA | - | - | - | - |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% | 52.377% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% | 72.449% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% | 57.579% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% | 62.154% |
Comments by matumba for this prediction
In the thread Epigenomics AG NA diskutieren
einsteigen
ich tat mir anfangs schwer, halte aber die aktien seit längeren,
jetzt kaufe ich sogar nach:
Epigenomics künftiger CFO überzeugt genauso wie Epi ProColon 2.0
Mannheim (aktiencheck.de AG) - Thomas Schießle, Analyst von MIDAS Research,
stuft die Aktie von Epigenomics (ISIN DE000A0BVT96/ WKN A0BVT9) unverändert mit dem Rating "langfristig kaufen" ein. Das neu...
(Laufzeit überschritten)